Lipoprotein(a) levels in women with pre-eclampsia and in normotensive pregnant women

被引:25
作者
Baksu, B
Baksu, A
Davas, I
Akyol, A
Gülbaba, G
机构
[1] Sisli Etfal Training & Res Hosp 2, Obstet & Gynecol Clin, Istanbul, Turkey
[2] Sisli Etfal Training & Res Hosp 1, Obstet & Gynecol Clin, Istanbul, Turkey
[3] Univ London, St Bartholomews & Royal London Sch Med & Dent, Wolfson Inst Prevent Med, London WC1E 7HU, England
关键词
etiology; lipids; lipoprotein(a); pre-eclampsia;
D O I
10.1111/j.1447-0756.2005.00276.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Aim: To determine if plasma lipoprotein(a) levels are elevated in pre-eclampsia and if so, their association with the severity of the disease. Methods: Ninety-one pre-eclamptic (48 mild, 43 severe) and 40 healthy normotensive pregnant women at more than 32 gestational weeks were recruited into study. Plasma levels of lipoprotein(a), lipids, total protein, albumin and fibrinogen were measured in all subjects. Results: All groups were comparable with respect to maternal age, maternal weight, gravidity and parity. Platelet count, total serum protein and albumin levels were significantly decreased, whereas fibrinogen levels significantly increased in the pre-eclamptic group. There was no difference between the groups with respect to total cholesterol and low-density lipoprotein levels. In the pre-eclampsic group, triglyceride and very-low-density lipoprotein concentrations were significantly higher, whereas high-density lipoprotein levels were significantly lower. No difference in serum lipoprotein(a) levels was found between the three groups. Conclusions: No statistically significant difference existed between normotensive pregnant, and pre-eclamptic women, with regard to plasma lipoprotein(a) levels. It is improbable that high serum lipoprotein(a) levels are risk factors for the development of pre-eclampsia; however, elevated triglyceride-rich lipoproteins might cause endothelial damage leading to pre-eclampsia.
引用
收藏
页码:277 / 282
页数:6
相关论文
共 31 条
[1]   Correlation of P-selectin and lipoprotein(a), and other lipid parameters in preeclampsia [J].
Aksoy, H ;
Kumtepe, Y ;
Akçay, F ;
Yildirim, AK .
CLINICAL AND EXPERIMENTAL MEDICINE, 2002, 2 (01) :39-43
[2]  
ALBERS JJ, 1990, CLIN CHEM, V36, P2019
[3]   LP(A) LIPOPROTEIN - AN OVERVIEW [J].
BERG, K .
CHEMISTRY AND PHYSICS OF LIPIDS, 1994, 67-8 :9-16
[4]   Plasma lipid and lipoprotein concentrations in pregnancy induced hypertension [J].
Cekmen, MB ;
Erbagci, AB ;
Balat, A ;
Duman, C ;
Maral, H ;
Ergen, K ;
Ozden, M ;
Balat, O ;
Kuskay, S .
CLINICAL BIOCHEMISTRY, 2003, 36 (07) :575-578
[5]  
Cunningham FG, 1997, WILLIAMS OBSTET, P693
[6]   LP(A) LIPOPROTEIN IN CARDIOVASCULAR-DISEASE [J].
DAHLEN, GH .
ATHEROSCLEROSIS, 1994, 108 (02) :111-126
[7]  
Djurovic S, 1997, CLIN GENET, V52, P371
[8]  
ECEMIS T, 2003, GYNECOL OBSTET REPRO, V9, P4
[9]  
ETINGIN OR, 1991, J BIOL CHEM, V266, P2459
[10]   ACTIVATION OF TRANSFORMING GROWTH-FACTOR-BETA IS INHIBITED IN TRANSGENIC APOLIPOPROTEIN(A) MICE [J].
GRAINGER, DJ ;
KEMP, PR ;
LIU, AC ;
LAWN, RM ;
METCALFE, JC .
NATURE, 1994, 370 (6489) :460-462